Lexaria Bioscience
LEXX
LEXX
16 hedge funds and large institutions have $1.68M invested in Lexaria Bioscience in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
20% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 5
Holders
16
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$264K | |
| 2 | +$98K | |
| 3 | +$37K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$9K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$5.57K |
Top Sellers
| 1 | -$63K | |
| 2 | -$33K | |
| 3 | -$10.6K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$7.39K |
| 5 |
Citigroup
New York
|
-$4K |